Ellwood-Yen K - Search Results

1

Myc-driven murine prostate cancer shares molecular features with human prostate tumors.

Ellwood-Yen K, Graeber TG, Wongvipat J, Iruela-Arispe ML, Zhang J, Matusik R, Thomas GV, Sawyers CL. Ellwood-Yen K, et al. Cancer Cell. 2003 Sep;4(3):223-38. doi: 10.1016/s1535-6108(03)00197-1. Cancer Cell. 2003. PMID: 14522256 Free article.

2

Context-dependent hormone-refractory progression revealed through characterization of a novel murine prostate cancer cell line.

Watson PA, Ellwood-Yen K, King JC, Wongvipat J, Lebeau MM, Sawyers CL. Watson PA, et al. Among authors: ellwood yen k. Cancer Res. 2005 Dec 15;65(24):11565-71. doi: 10.1158/0008-5472.CAN-05-3441. Cancer Res. 2005. PMID: 16357166

3

Transgenic mouse model for rapid pharmacodynamic evaluation of antiandrogens.

Ellwood-Yen K, Wongvipat J, Sawyers C. Ellwood-Yen K, et al. Cancer Res. 2006 Nov 1;66(21):10513-6. doi: 10.1158/0008-5472.CAN-06-1397. Cancer Res. 2006. PMID: 17079473

4

A prostatic intraepithelial neoplasia-dependent p27 Kip1 checkpoint induces senescence and inhibits cell proliferation and cancer progression.

Majumder PK, Grisanzio C, O'Connell F, Barry M, Brito JM, Xu Q, Guney I, Berger R, Herman P, Bikoff R, Fedele G, Baek WK, Wang S, Ellwood-Yen K, Wu H, Sawyers CL, Signoretti S, Hahn WC, Loda M, Sellers WR. Majumder PK, et al. Among authors: ellwood yen k. Cancer Cell. 2008 Aug 12;14(2):146-55. doi: 10.1016/j.ccr.2008.06.002. Cancer Cell. 2008. PMID: 18691549 Free PMC article.

5

Hepsin cooperates with MYC in the progression of adenocarcinoma in a prostate cancer mouse model.

Nandana S, Ellwood-Yen K, Sawyers C, Wills M, Weidow B, Case T, Vasioukhin V, Matusik R. Nandana S, et al. Among authors: ellwood yen k. Prostate. 2010 May 1;70(6):591-600. doi: 10.1002/pros.21093. Prostate. 2010. PMID: 19938013 Free PMC article.

6

MYC cooperates with AKT in prostate tumorigenesis and alters sensitivity to mTOR inhibitors.

Clegg NJ, Couto SS, Wongvipat J, Hieronymus H, Carver BS, Taylor BS, Ellwood-Yen K, Gerald WL, Sander C, Sawyers CL. Clegg NJ, et al. Among authors: ellwood yen k. PLoS One. 2011 Mar 4;6(3):e17449. doi: 10.1371/journal.pone.0017449. PLoS One. 2011. PMID: 21394210 Free PMC article.

7

The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth.

Jin RJ, Lho Y, Connelly L, Wang Y, Yu X, Saint Jean L, Case TC, Ellwood-Yen K, Sawyers CL, Bhowmick NA, Blackwell TS, Yull FE, Matusik RJ. Jin RJ, et al. Among authors: ellwood yen k. Cancer Res. 2008 Aug 15;68(16):6762-9. doi: 10.1158/0008-5472.CAN-08-0107. Cancer Res. 2008. PMID: 18701501 Free PMC article.

8

BCR-ABL point mutants isolated from patients with imatinib mesylate-resistant chronic myeloid leukemia remain sensitive to inhibitors of the BCR-ABL chaperone heat shock protein 90.

Gorre ME, Ellwood-Yen K, Chiosis G, Rosen N, Sawyers CL. Gorre ME, et al. Among authors: ellwood yen k. Blood. 2002 Oct 15;100(8):3041-4. doi: 10.1182/blood-2002-05-1361. Blood. 2002. PMID: 12351420 Free article.

9

PDK1 attenuation fails to prevent tumor formation in PTEN-deficient transgenic mouse models.

Ellwood-Yen K, Keilhack H, Kunii K, Dolinski B, Connor Y, Hu K, Nagashima K, O'Hare E, Erkul Y, Di Bacco A, Gargano D, Shomer NH, Angagaw M, Leccese E, Andrade P, Hurd M, Shin MK, Vogt TF, Northrup A, Bobkova EV, Kasibhatla S, Bronson RT, Scott ML, Draetta G, Richon V, Kohl N, Blume-Jensen P, Andersen JN, Kraus M. Ellwood-Yen K, et al. Cancer Res. 2011 Apr 15;71(8):3052-65. doi: 10.1158/0008-5472.CAN-10-2282. Cancer Res. 2011. PMID: 21493594

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page